View Complaint
Retainer Agreement
info@rosenlegal.com

Zosano Pharma shareholders have an opportunity to recover their investment losses.

Click "Join this Class Action" above.

Attorneys

Zosano Pharma Corporation

Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Zosano Pharma Corporation (NASDAQ: ZSAN) resulting from allegations that Zosano Pharma may have issued materially misleading business information to the investing public.

If you purchased shares of Zosano Pharma and would like to join the action, please click "Join This Class Action" above.

Press Release

EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Zosano Pharma Corporation - ZSAN

New York, N.Y., April 14, 2016.  Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Zosano Pharma Corporation (NASDAQ: ZSAN) resulting from allegations that Zosano Pharma may have issued materially misleading business information to the investing public.

On January 27, 2015, Zosano Pharma sold 6.5 million shares of stock in its initial public offering (the “IPO”), raising over $71 million in new capital. Upon news of the alleged failure of Zosano Pharma’s lead osteoporosis drug program to reach commercial viability, shares of Zosano Pharma fell dramatically in value from its IPO price of $11 per share and closed at $2.35 per share on April 7, 2016.

Rosen Law Firm is preparing a class action lawsuit to recover losses suffered by Zosano Pharma investors. If you purchased shares of Zosano Pharma, please visit the firm’s website at http://rosenlegal.com/cases-876.html for more information. You may also contact Phillip Kim, Esq. or Kevin Chan, Esq. of Rosen Law Firm toll free at 866-767-3653 or via email at pkim@rosenlegal.com or kchan@rosenlegal.com.

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.

Attorney Advertising.  Prior results do not guarantee a similar outcome.

-------------------------------

Contact Information:

      Laurence Rosen, Esq.
      Phillip Kim, Esq.
      Kevin Chan, Esq.
      The Rosen Law Firm, P.A.
      275 Madison Avenue, 34th Floor
      New York, NY  10016
      Tel: (212) 686-1060
      Toll Free: (866) 767-3653
      Fax: (212) 202-3827
      lrosen@rosenlegal.com
      pkim@rosenlegal.com
      kchan@rosenlegal.com
      www.rosenlegal.com